PROFFERED PAPERS
Tuesday, March 23   —  8:00 AM   —  Salon 3 & Balconies


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...




Section C - Breast Pathology
Chaired By: Geza Acs and Michael Gilcrease



TimeTitle and AuthorsItinerary
Planner
8:00 Invasive Apocrine Carcinomas Are Molecularly Diverse Group of Breast Cancers (197)
Z Gatalica, S Vranic. - Creighton University School of Medicine, Omaha, NE.
Add
8:15 Relation of Hormone Receptor and Her2 Expression to Apocrine Cytology in 305 Grade III Breast Carcinomas (241)
K Killoran, CA Axiotis, X Song, V Patel, S Bordia, K Thompson, AS Braverman. - SUNY Downstate Medical Center, Brooklyn, NY; Kings County Hospital Center, Brooklyn, NY; Kings County Medical Center, Brooklyn, NY.
Add
8:30 Prognostic Factors of Primary Invasive Mammary Neuroendocrine Carcinoma: Clinicopathologic Analysis of 74 Cases (336)
B Wei, Z Tian, F Tang, W Wei, MZ Gilcrease, L Huo, CT Albarracin, E Resetkova, LP Middleton, A Sahin, J Chen, SC Abraham, Y Wu. - West China Hospital, Sichuan University, Chengdu, Sichuan, China; Ninth People's Hospital, Shanghai Jiao Tong University, Shanghai, China; Huashan Hospital, Fudan University, Shanghai, China; The University of Texas MD Anderson Cancer Center, Houston, TX
Add
8:45 Mucinous Carcinoma of Breast: A Retrospective Review of 100 Cases over 9 Year Period with emphasis on axillary Staging (292)
A Ranade, R Batra, J Balderacchi. - St Lukes Roosevelt and Beth Israel Medical Center, New York, NY.
Add
9:00 Molecular Characterisation of Mucinous Carcinomas of the Breast — A Genomic Profiling Analysis (248)
M Lacroix-Triki, P Saurez, MB Lambros, R Natrajan, A Mackay, FC Geyer, A Ashworth, JS Reis-Filho. - Institut Claudius Regaud, Toulouse, France; ICR, London, United Kingdom.
Add
9:15 Invasive Lobular Carcinoma of the Breast. A Clinicopathologic Study of 1,200 Cases (139)
I Alvarado-Cabrero, R Valencia-Cedillo, J Castro-Garcia, G Picon-Coronel, S Barroso-Bravo. - Mexican Oncology Hospital, Mexico, DF, Mexico.
Add
9:30 RECESS, EXHIBITS, POSTER SESSION III  
11:00 Expression of Id4, a BRCA1 Downregulator, in Triple Negative Breast Cancer (339)
YH Wen, M Akram, T Nehhozina, Z Bowser, L Norton, E Brogi. - Memorial Sloan-Kettering Cancer Center, New York, NY.
Add
11:15 TMEPAI Gene Amplification in Triple Negative Breast Cancers (304)
N Samarnthai, P Saikumar, P Singha, MA Ventkatachalam, SR Gunn, I Yeh. - University of Texas Health Science Center at San Antonio, San Antonio, TX.
Add
11:30 A Distinct Gene Expression Profile Is Associated with aggressive Breast Carcinomas (BC) Showing Prominent retraction artifact (RA) (289)
Z Rakosy, G Paragh, G Acs. - Moffitt Cancer Center, Tampa, FL.
Add
11:45 Expression of Stem Cell Marker (ALDH1) Correlates with Aggressive Molecular Subtypes of Breast Cancer (276)
S Nofech-Mozes, J Zubovits, H Kahn, J Wong, RS Saad, A Seth, M Yaffe, C Peressotti, G Clarke, WM Hanna. - Sunnybrook Health Sciences Centre, Toronto, Canada.
Add